Kohlberg Kravis Roberts & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,695,984	Closed	-$664M	–	55
2019 Q2	$664M	Hold	6,695,984	–	–	8.18%	4
2019 Q1	$739M	Hold	6,695,984	–	–	11.24%	3
2018 Q4	$616M	Hold	6,695,984	–	–	11.23%	2
2018 Q3	$738M	Sell	6,695,984 -6,500,000	-49%	-$677M	8.37%	4
2018 Q2	$1.23B	Hold	13,195,984	–	–	14.03%	3
2018 Q1	$1.09B	Hold	13,195,984	–	–	13.31%	2
2017 Q4	$1.2B	Hold	13,195,984	–	–	11.83%	3
2017 Q3	$1.01B	Sell	13,195,984 -9,500,000	-42%	-$718M	11.61%	2
2017 Q2	$1.7B	Hold	22,695,984	–	–	19.29%	2
2017 Q1	$1.48B	Hold	22,695,984	–	–	26.57%	2
2016 Q4	$1.25B	Sell	22,695,984 -7,500,000	-25%	-$412M	19.96%	2
2016 Q3	$1.71B	Hold	30,195,984	–	–	21.18%	3
2016 Q2	$1.26B	Sell	30,195,984 -4,907,692	-14%	-$226M	13.28%	3
2016 Q1	$1.5B	Sell	35,103,676 -4,829,981	-12%	-$204M	14.87%	2
2015 Q4	$1.81B	Hold	39,933,657	–	–	17.59%	2
2015 Q3	$1.55B	Hold	39,933,657	–	–	16.48%	2
2015 Q2	$1.45B	Hold	39,933,657	–	–	13.1%	2
2015 Q1	$1.15B	Hold	39,933,657	–	–	11.94%	2
2014 Q4	$967M	Buy	+39,933,657	New	+$900M	12.62%	3

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's PRAH Position: Q3 2019 in Review

Kohlberg Kravis Roberts & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 6,695,984 shares — an estimated $664M sold.

Kohlberg Kravis Roberts & Co first reported a position in PRAH in Q4 2014 and held it in 19 quarters. The position peaked at $1.81B in Q4 2015. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

Kohlberg Kravis Roberts & Co reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
Kohlberg Kravis Roberts & Co sold 6,695,984 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $664M.
Kohlberg Kravis Roberts & Co first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 19 quarters.
Kohlberg Kravis Roberts & Co's PRA Health Sciences, Inc. position peaked at $1.81B in Q4 2015.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2019, filed 14 Nov 2019.